These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2021107)

  • 21. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonazepam treatment of obsessions and compulsions.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychiatry; 1990 Apr; 51(4):158-61. PubMed ID: 2182614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
    Amin MM; Ban TA; Pecknold JC; Klingner A
    J Int Med Res; 1977; 5 Suppl 5():33-7. PubMed ID: 340305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous anti-obsessive agents: a review.
    Ravindran LN; Jung SM; Ravindran AV
    J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clomipramine: a tricyclic antidepressant effective in obsessive compulsive disorder.
    Kelly MW; Myers CW
    DICP; 1990; 24(7-8):739-44. PubMed ID: 2197816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
    McTavish D; Benfield P
    Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience in the treatment of obsessional states (2).
    Rack PH
    J Int Med Res; 1977; 5 Suppl 5():81-90. PubMed ID: 598609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
    Zhao JP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):68-70, 123. PubMed ID: 1860383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anafranil in obsessive compulsive neurosis.
    Wyndowe J; Solyom L; Ananth J
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
    [No Abstract]   [Full Text] [Related]  

  • 35. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 37. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN; Sexena B; Gent M
    J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological bases of obsessive-compulsive disorder].
    López-Ibor Aliño JJ; Viñas Pifarré R; Saiz Ruiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(5):306-15. PubMed ID: 1981298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic studies in obsessional patients.
    Luscombe DK; Marks IM
    J Int Med Res; 1977; 5 Suppl 5():91-6. PubMed ID: 598610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.